Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls.
Madalena Souto MouraJoão CostaValérie VelascoFelix KommossEsther OlivaFrançois Le LoarerW Glenn McCluggageRubina RazackIsabelle TreilleuxAnne MillsTeri LongacreMojgan Devouassoux-ShisheboranIsabelle HosteinRihab AzmaniLarry BlanchardCécile HartogIsabelle SoubeyranEmmanuel KhalifaSabrina CrocePublished in: Histopathology (2023)
Even though pan-TRK immunohistochemical expression is not entirely sensitive or specific for NTRK-rearranged sarcomas, these neoplasms tend to exhibit diffuse staining of moderate/strong intensity, unlike its mimics. Pan-TRK should be performed in monomorphic uterine (corpus and cervix) spindle cell neoplasms that are negative for smooth muscle markers and hormone receptors and positive for CD34 and/ or S100. Ultimately, the diagnosis requires molecular confirmation.